Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) said management will attend two investor healthcare conferences in May and June 2026.

Executives will hold 1-to-1 investor meetings at the BofA Securities 2026 Health Care Conference on May 13, 2026, and a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, with a live audio webcast available on the investor site.

News Market Reaction – MYGN

+4.89%

11 alerts

+4.89% Session close to close

+2.1% Peak in 1 hr 48 min

$413.19M Market Cap

0.4x Rel. Volume

In the May 8 session, MYGN gained 4.89%, reflecting a moderate positive market reaction. Argus tracked a peak move of +2.1% during that session. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, May 07, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.

• The BofA Securities 2026 Health Care Conference – 1-to-1 investor meetings taking place Wednesday, May 13, 2026.
  
• Goldman Sachs 47^th Annual Global Healthcare Conference – fireside chat at 8:40 a.m. ET on Wednesday, June 10, 2026.
  
  

The Goldman Sachs presentation will be available through live audio webcast links in the investor information section of Myriad’s website at investor.myriad.com.

About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. For more information, visit www.myriad.com.

Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact
Kate Schraml
(224) 875-4493
PR@myriad.com

FAQ

When will Myriad Genetics (MYGN) present at the Goldman Sachs healthcare conference in 2026?

Myriad will present on June 10, 2026 at 8:40 a.m. ET. According to Myriad, the presentation will be delivered as a fireside chat and made available via live audio webcast on the company's investor website.

What investor events will Myriad Genetics (MYGN) attend in May and June 2026?

Myriad management will attend two events: BofA 2026 Health Care Conference meetings on May 13, 2026 and a Goldman Sachs fireside chat on June 10, 2026. According to Myriad, the Goldman Sachs session will be webcast live.

How can investors access Myriad Genetics (MYGN) Goldman Sachs presentation webcast?

Investors can access the live audio webcast via Myriad's investor website at investor.myriad.com. According to Myriad, the Goldman Sachs presentation link will be posted in the investor information section for on-demand listening.

Will Myriad Genetics (MYGN) hold 1-to-1 investor meetings at BofA in 2026?

Yes, Myriad management will hold 1-to-1 investor meetings at the BofA Securities 2026 Health Care Conference on May 13, 2026. According to Myriad, these are scheduled investor meetings rather than a public webcast presentation.